Development of a clinical type 1 diabetes metabolic system model and in Silico simulation tool

Journal of Diabetes Science and Technology

Volumn 2, Issue 3, 2008, Pages 424-435

  Wong, Xing Wei ^a   Chase, J Geoffrey ^a   Hann, Christopher E ^a   Lotz, Thomas F ^a   Lin, Jessica ^a   Le Compte, Aaron J ^a   Shaw, Geoffrey M ^b  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Blood glucose; Compartmental models; Decision support; Diabetes; Hyperglycemia; Insulin; Simulation; Subcutaneous injection

Indexed keywords

EID: 70349760461     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200312     Document Type: Conference Paper

References (57)

1. Bequette BW. A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol Ther. 2005;7(1):28-47.
2. Bellazzi R, Nucci G, Cobelli C. The subcutaneous route to insulin-dependent diabetes therapy. IEEE Eng Med Biol Mag. 2001;20(1):54-64.
3. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes. 2006;55(12):3344-50.
4. Steil GM, Panteleon AE, Rebrin K. Closed-loop insulin delivery - the path to physiological glucose control. Adv Drug Deliv Rev. 2004;56(2):125-44.
5. Klonoff DC, Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care. 2005;28(5):1231-9.
6. Guidance on the use of continuous subcutaneous insulin infusion for diabetes. Technology Appraisal Guidance No. 57, National Institute for Clinical Excellence; 2003. Available from: www.nice.org.uk.
7. Position statement on insulin pump therapy. Position statement on insulin pump therapy, Diabetes UK [cited 2007 Aug. 8]. Available from: www.diabetes.org.uk.
8. ADA. Standards of medical care in diabetes-2006. Diabetes Care. 2006;29; S4-S42.
9. Mainous AG 3rd, Diaz VA, Saxena S, Baker R, Everett CJ, Koopman RJ, Majeed A. Diabetes management in the USA and England: comparative analysis of national surveys. J R Soc Med. 2006;99(9):463-9.
10. Cohen M, Boyle E, Delaney C, Shaw J. A comparison of blood glucose meters in Australia. Diabetes Res Clin Pract. 2006;71(2):113-8.
11. Guerci B, Floriot M, Böhme P, Durain D, Benichou M, Jellimann S, Drouin P. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care. 2003;26(3):582-9.
12. Gerich JE. Novel insulins: Expanding options in diabetes management. Am J Med. 2002;113(4):308-16.
13. Wong J, Chase JG, Hann CE, Lotz TF, Lin J, Le Compte A, Shaw GM. Monte Carlo analysis of an adaptive protocol for the clinical control of type 1 diabetes. Diabetes Sci Technol. 2008;2(3): in preparation.
14. Chase JG, Shaw GM, Lin J, Doran CV, Hann C, Robertson MB, Browne PM, Lotz T, Wake GC, Broughton B. Adaptive bolus-based targeted glucose regulation of hyperglycaemia in critical care. Med Eng Phys. 2005;27(1):1-11.
15. Wong XW, Singh-Levett I, Hollingsworth LJ, Shaw GM, Hann CE, Lotz T, Lin J, Wong OS, Chase JG. A novel, model-based insulin and nutrition delivery controller for glycemic regulation in critically ill patients. Diabetes Technol Ther. 2006;8(2):174-90.
16. Johansen K, Svendsen PA, Lørup B. Variations in renal threshold for glucose in Type 1 (insulin-dependent) diabetes-mellitus. Diabetologia. 1984;26(3):180-2.
17. Lehmann ED, Deutsch T, Carson ER, Sönksen PH. Aida: an interactive diabetes adviser. Comput Methods Programs Biomed. 1994;41(3-4):183-203.
18. Lehmann ED, Deutsch T. A physiological model of glucoseinsulin interaction in type 1 diabetes mellitus. J Biomed Eng. 1992;14(3):235-42.
19. Arleth T, Andreassen S, Federici MO, Benedetti MM. A model of the endogenous glucose balance incorporating the characteristics of glucose transporters. Comput Methods Programs Biomed. 2000;62(3):219-34.
20. Binder C. Absorption of injected insulin. A clinical-pharmacological study. Acta Pharmacol Toxicol (Copenh). 1969;27 Suppl 2:1-84.
21. Wong J, Chase JG, Hann CE, Shaw GM, Lotz TF, Lin J, Le Compte AJ. A subcutaneous insulin pharmacokinetic model for computer simulation in a diabetes decision support role: validation and simulation. J Diabetes Sci Technol. In press 2008.
22. Wong J, Chase JG, Hann CE, Shaw GM, Lotz TF, Lin J, Le Compte AJ. A subcutaneous insulin pharmacokinetic model for computer simulation in a diabetes decision support role: model structure and parameter identification. J Diabetes Sci Technol. In press 2008.
23. Yates TL, Fletcher LR. Prediction of a glucose appearance function from foods using deconvolution. Ima J Math Appl Med Biol. 2000;17(2):169-84.
24. Wolever TM, Bolognesi C. Source and amount of carbohydrate affect postprandial glucose and insulin in normal subjects. J Nutr. 1996;126(11):2798-806.
25. Wolever TM, Bolognesi C. Prediction of glucose and insulin responses of normal subjects after consuming mixed meals varying in energy, protein, fat, carbohydrate and glycemic index. J Nutr. 1996;126(11):2807-12.
26. Dalla Man C, Camilleri M, Cobelli C. A system model of oral glucose absorption: validation on gold standard data. IEEE Trans Biomed Eng. 2006;53(12 Pt 1):2472-8.
27. Bruttomesso D, Pianta A, Crazzolara D, Capparotto C, Dainese E, Zurlo C, Minicuci N, Briani G, Tiengo A. Teaching and training programme on carbohydrate counting in Type 1 diabetic patients. Diabetes Nutr Metab. 2001;14(5):259-67.
28. Warshaw HS, Kulkarni K. Complete guide to carb counting: how to take the mystery out of carb counting and unlock the secrets to blood glucose control. 2nd ed. Virginia: American Diabetes Association; 2004.
29. Gregory RP, Davis DL. Use of carbohydrate counting for meal planning in type I diabetes. Diabetes Educ. 1994;20(5):406-9.
30. Flint A, Møller BK, Raben A, Pedersen D, Tetens I, Holst JJ, Astrup A. The use of glycaemic index tables to predict glycaemic index of composite breakfast meals. Br J Nutr. 2004;91(6):979-89.
31. Worthington DR. Minimal model of food absorption in the gut. Med Inform (Lond). 1997;22(1):35-45.
32. Korach-André M, Roth H, Barnoud D, Péan M, Péronnet F, Leverve X. Glucose appearance in the peripheral circulation and liver glucose output in men after a large 13C starch meal. Am J Clin Nutr. 2004;80(4):881-6.
33. Guyton AC, Hall JE. Textbook of medical physiology. 10th ed. London: Saunders; 2000.
34. Dalla Man C, Caumo A, Basu R, Rizza R, Toffolo G, Cobelli C. Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. Am J Physiol Endocrinol Metab. 2004;287(4):E637-43.
35. Noah L, Krempf M, Lecannu G, Maugère P, Champ M. Bioavailability of starch and postprandial changes in splanchnic glucose metabolism in pigs. Am J Physiol Endocrinol Metab. 2000;278(2):E181-8.
36. Mari A, Wahren J, De Fronzo RA, Ferrannini E. Glucose absorption and production following oral glucose: comparison of compartmental and arteriovenous-difference methods. Metabolism 1994;43(11):1419-25.
37. Ferrannini E, Bjorkman O, Reichard GA Jr, Pilo A, Olsson M, Wahren J, De Fronzo RA. The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes. 1985;34(6):580-8.
38. Capaldo B, Gastaldelli A, Antoniello S, Auletta M, Pardo F, Ciociaro D, Guida R, Ferrannini E, Saccà L. Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes. 1999;48(5):958-66.
39. Livesey G, Wilson PD, Dainty JR, Brown JC, Faulks RM, Roe MA, Newman TA, Eagles J, Mellon FA, Greenwood RH. Simultaneous time-varying systemic appearance of oral and hepatic glucose in adults monitored with stable isotopes. Am J Physiol. 1998;275(4 Pt 1):E717-28.
40. Del Prato S, Matsuda M, Simonson DC, Groop LC, Sheehan P, Leonetti F, Bonadonna RC, De Fronzo RA. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance. Diabetologia. 1997;40(6):687-97.
41. Del Prato S, Riccio A, Vigili de Kreutzenberg S, Dorella M, Tiengo A, De Fronzo RA. Basal plasma insulin levels exert a qualitative but not quantitative effect on glucose-mediated glucose uptake. Am J Physiol. 1995;268(6 Pt 1):E1089-95.
42. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol. 1979;236(6):E667-77.
43. Siesjö BK. Hypoglycemia, brain metabolism, and brain damage. Diabetes Metab Rev. 1988;4(2):113-44.
44. Best JD, Taborsky GJ Jr, Halter JB, Porte D Jr. Glucose disposal is not proportional to plasma glucose level in man. Diabetes. 1981;30(10):847-50.
45. Baron AD, Brechtel G, Wallace P, Edelman SV. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol. 1988;255(6 Pt 1):E769-74.
46. Best JD, Kahn SE, Ader M, Watanabe RM, Ni TC, Bergman RN. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care. 1996;19(9):1018-30.
47. Scheinberg P. Observations on cerebral carbohydrate metabolism in man. Ann Intern Med. 1965;62:367-71.
48. Boyle PJ, Scott JC, Krentz AJ, Nagy RJ, Comstock E, Hoffman C. Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans. J Clin Invest. 1994;93(2):529-35.
49. Reed K, Lehmann ED. Diabetes website review: www.2aida.org. Diabetes Technol Ther. 2005;7(5):741-54.
50. Chase JG, Shaw GM, Lotz T, Le Compte A, Wong J, Lin J, Lonergan T, Willacy M, Hann CE. Model-based insulin and nutrition administration for tight glycaemic control in critical care. Curr Drug Deliv. 2007;4(4):283-96.
51. Chase JG, Wong XW, Singh-Levett I, Hollingsworth LJ, Hann CE, Shaw GM, Lotz T, Lin J. Simulation and initial proof-of-concept validation of a glycaemic regulation algorithm in critical care. Control Eng Pract. In press 2008.
52. Lonergan T, Le Compte A, Willacy M, Chase JG, Shaw GM, Wong XW, Lotz T, Lin J, Hann CE. A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. Diabetes Technol Ther. 2006;8(2):191-206.
53. Hann CE, Chase JG, Lin J, Lotz T, Doran CV, Shaw GM. Integralbased parameter identification for long-term dynamic verification of a glucose-insulin system model. Comput Methods Programs Biomed. 2005;77(3):259-70.
54. Lehmann ED, Deutsch T. AIDA2: a Mk. II automated insulin dosage advisor. J Biomed Eng. 1993;15(3):201-11.
55. BD Diabetes Learning Centre. Insulin therapies. Managing diabetes with insulin. 2006. Available from: http://www.bddiabetes.com/us/main.aspx?cat= 1&id=151.
56. Walsh J, Roberts R. The pocket pancreas: your diabetes guide for improved blood sugars. Diabetes Services Inc.; 1994.
57. Hanas R. Type 1 diabetes: a guide for children, adolescents, young adults and their caregivers. New York: Marlowe & Company; 2005.